Prognostic value of bcl‐6, CD10 and CD38 immunoreactivity in stage I–II gastric lymphomas: Identification of a subset of CD10<sup>+</sup> large B‐cell lymphomas with a favorable outcome
Maurilio Ponzoni(San Raffaele University of Rome), Carlo Capella(University of Insubria), Massimo Freschi(San Raffaele University of Rome), Giancarlo Pruneri(University of Milan), Alessandra Pigni(Ospedale di Circolo e Fondazione Macchi), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Giuseppe Viale(University of Milan), Eugenio Villa(IRCCS Ospedale San Raffaele), Stefania Dell’Oro(San Raffaele University of Rome), Graziella Pinotti(Medica (Italy)), Barbara Pozzi(University of Insubria)
Cited by 28
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version)
|Archives of Pathology & Laboratory Medicine|2010|1.1k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2010|898
HER2-Low Breast Cancer: Pathological and Clinical Landscape
|Journal of Clinical Oncology|2020|801